Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12215138
Compositions and methods for internalizing enzymes
granted -
US 12215131
IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof
granted -
US 12215322
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors
granted -
US 12214023
Compositions and methods for expressing factor IX
granted -
US 12209180
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists
granted -
US 12209238
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
granted -
US 12202883
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 12186378
Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
granted -
US 12187772
IL10 agonists and methods of use thereof
granted -
US 12187792
IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
granted -
US 12180272
Antigen binding molecule formats
granted -
US 12168036
Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins
granted -
US 12169199
Activity based host cell protein profiling
granted -
US 12168681
Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
granted -
US 12163192
Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof
granted -
US 12162943
High affinity human antibodies to human IL-4 receptor
granted -
US 12161097
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 12157758
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 12157891
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
granted -
US 12152067
Human antibodies to ebola virus glycoprotein
granted -
US 12150959
Chimeric antigen receptors with BCMA specificity and uses thereof
granted -
US 12144864
Tubulysins and protein-tubulysin conjugates
granted -
US 12139546
Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
granted